Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -1.29%16.75B | 2.25%16.89B | 3.55%17.9B | 3.55%17.9B | 2.04%17.31B | -7.00%16.97B | -6.54%16.52B | -11.66%17.28B | -11.66%17.28B | -11.25%16.96B |
-Cash and cash equivalents | -4.87%15.95B | -0.16%16.19B | 1.86%17.3B | 1.86%17.3B | 2.07%17.01B | -7.07%16.77B | -7.18%16.22B | -12.29%16.98B | -12.29%16.98B | -10.95%16.66B |
-Short term investments | 298.89%798.17M | 132.58%697.61M | 98.94%596.29M | 98.94%596.29M | -0.00%299.72M | -0.30%200.1M | 50.05%299.94M | 49.86%299.74M | 49.86%299.74M | -25.15%299.72M |
Receivables | -3.37%2.92B | -17.03%2.64B | -11.04%2.88B | -11.04%2.88B | -10.29%2.87B | -8.16%3.02B | 6.41%3.19B | 8.91%3.23B | 8.91%3.23B | 5.86%3.2B |
-Accounts receivable | -3.37%2.92B | -17.03%2.64B | -11.04%2.88B | -11.04%2.88B | -10.29%2.87B | -8.16%3.02B | 6.41%3.19B | 8.91%3.23B | 8.91%3.23B | 5.86%3.2B |
-Gross accounts receivable | -3.37%2.92B | -17.03%2.64B | -11.04%2.88B | -11.04%2.88B | -10.29%2.87B | -8.16%3.02B | 6.41%3.19B | 8.91%3.23B | 8.91%3.23B | 5.86%3.2B |
Other current assets | 13.66%305.02M | 6.10%382.99M | -16.76%381.66M | -16.76%381.66M | -59.07%414.44M | -4.04%268.36M | -63.17%360.99M | 3.70%458.5M | 3.70%458.5M | 108.16%1.01B |
Total current assets | -1.40%19.98B | -0.74%19.92B | 0.85%21.16B | 0.85%21.16B | -2.75%20.59B | -7.14%20.26B | -7.31%20.07B | -8.70%20.98B | -8.70%20.98B | -6.40%21.18B |
Non current assets | ||||||||||
Net PPE | -30.85%62.05M | -8.06%86.54M | -7.81%92.26M | -7.81%92.26M | 2.35%109.15M | -10.34%89.73M | -5.41%94.12M | -1.00%100.07M | -1.00%100.07M | -8.94%106.64M |
-Gross PP&E | -30.85%62.05M | -8.06%86.54M | -7.81%92.26M | -7.81%92.26M | 2.35%109.15M | -10.34%89.73M | -5.41%94.12M | -1.00%100.07M | -1.00%100.07M | -8.94%106.64M |
Total investment | -36.27%1.27B | -21.88%1.46B | -24.72%1.4B | -24.72%1.4B | 15.81%1.82B | 50.25%1.99B | 48.48%1.86B | 117.83%1.86B | 117.83%1.86B | 93.07%1.57B |
-Financial asset investment | -36.27%1.27B | -21.88%1.46B | -24.72%1.4B | -24.72%1.4B | 15.81%1.82B | 50.25%1.99B | 48.48%1.86B | 117.83%1.86B | 117.83%1.86B | 93.07%1.57B |
-Including:Available-for-sale securities | -36.27%1.27B | -21.88%1.46B | -24.72%1.4B | -24.72%1.4B | 15.81%1.82B | 50.25%1.99B | 48.48%1.86B | 117.83%1.86B | 117.83%1.86B | 93.07%1.57B |
Goodwill and other intangible assets | 191.98%1.03B | 17.22%401.6M | 17.18%387.97M | 17.18%387.97M | -8.83%368.26M | -12.84%354.28M | -18.30%342.61M | -21.85%331.09M | -21.85%331.09M | -26.64%403.93M |
-Goodwill | --617.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other intangible assets | 17.79%417.33M | 17.22%401.6M | 17.18%387.97M | 17.18%387.97M | -8.83%368.26M | -12.84%354.28M | -18.30%342.61M | -21.85%331.09M | -21.85%331.09M | -26.64%403.93M |
Other non current assets | 35.86%441.83M | -0.59%537.79M | -41.80%340.52M | -41.80%340.52M | -43.75%302.54M | -26.28%325.22M | 76.41%541.01M | 95.25%585.09M | 95.25%585.09M | 73.25%537.89M |
Total non current assets | 1.67%2.81B | -12.65%2.48B | -22.79%2.22B | -22.79%2.22B | -0.78%2.6B | 21.46%2.76B | 36.56%2.84B | 71.41%2.88B | 71.41%2.88B | 46.17%2.62B |
Total assets | -1.03%22.78B | -2.22%22.4B | -2.00%23.38B | -2.00%23.38B | -2.53%23.19B | -4.44%23.02B | -3.47%22.91B | -3.24%23.86B | -3.24%23.86B | -2.54%23.79B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -9.73%4.46B | -12.87%4.14B | -6.58%4.62B | -6.58%4.62B | -0.01%4.65B | -1.22%4.94B | 9.43%4.75B | 15.46%4.94B | 15.46%4.94B | 13.42%4.65B |
-accounts payable | -5.48%4.31B | -10.79%4.08B | -3.21%4.32B | -3.21%4.32B | 3.47%4.52B | 0.13%4.56B | 10.20%4.57B | 12.60%4.46B | 12.60%4.46B | 10.25%4.37B |
-Total tax payable | -59.61%156.62M | -66.71%58.8M | -37.51%303.61M | -37.51%303.61M | -54.14%129.05M | -14.68%387.77M | -7.42%176.65M | 50.61%485.88M | 50.61%485.88M | 104.98%281.43M |
Current provisions | --17.51M | --10.49M | --7.94M | --7.94M | ---- | ---- | ---- | ---- | ---- | ---- |
Pension and other retirement benefit plans | 4.10%9.73M | 2.03%6.67M | -74.81%3.44M | -74.81%3.44M | 11.53%12.25M | 10.98%9.35M | 7.69%6.54M | 337.23%13.66M | 337.23%13.66M | 32.23%10.98M |
Other current liabilities | 2.24%698.36M | -0.06%951.44M | -7.99%741.98M | -7.99%741.98M | 9.44%769.27M | -1.76%683.05M | 3.90%952M | 54.51%806.42M | 54.51%806.42M | 9.12%702.92M |
Current liabilities | -7.94%5.19B | -10.53%5.11B | -6.80%5.37B | -6.80%5.37B | 1.25%5.43B | -1.26%5.64B | 8.46%5.71B | 19.91%5.76B | 19.91%5.76B | 11.51%5.37B |
Non current liabilities | ||||||||||
Other non current liabilities | -13.72%117.22M | -17.03%113.72M | -14.46%117.36M | -14.46%117.36M | -12.11%119.98M | 0.60%135.85M | -0.11%137.05M | -3.31%137.2M | -3.31%137.2M | -3.91%136.51M |
Total non current liabilities | -13.72%117.22M | -17.03%113.72M | -14.46%117.36M | -14.46%117.36M | -12.11%119.98M | 0.60%135.85M | -0.11%137.05M | -3.31%137.2M | -3.31%137.2M | -3.91%136.51M |
Total liabilities | -8.08%5.31B | -10.68%5.22B | -6.98%5.49B | -6.98%5.49B | 0.92%5.55B | -1.22%5.77B | 8.24%5.84B | 19.24%5.9B | 19.24%5.9B | 11.07%5.5B |
Shareholders'equity | ||||||||||
Share capital | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B |
-common stock | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B | 0.00%1.17B |
Additional paid-in capital | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M | 0.00%278.37M |
Retained earnings | 0.99%20.62B | 0.14%20.31B | -0.46%21.05B | -0.46%21.05B | -0.69%20.79B | -0.32%20.42B | 1.35%20.28B | 0.90%21.15B | 0.90%21.15B | 1.20%20.94B |
Less: Treasury stock | 0.00%4.78B | 0.00%4.78B | 0.53%4.78B | 0.53%4.78B | 13.23%4.78B | 25.77%4.78B | 47.94%4.78B | 69.79%4.75B | 69.79%4.75B | 52.36%4.22B |
Other reserves | 74.64%129.79M | 270.54%113.23M | 192.68%80.07M | 192.68%80.07M | 93.74%91.51M | 122.45%74.32M | 23.63%30.56M | 34.69%27.36M | 34.69%27.36M | 168.98%47.23M |
Other equity interest | -34.63%53.1M | 6.30%84.83M | 7.02%83.53M | 7.02%83.53M | 7.52%82.54M | 8.30%81.24M | 8.50%79.8M | 9.95%78.05M | 9.95%78.05M | 6.49%76.77M |
Total stockholders'equity | 1.33%17.48B | 0.68%17.18B | -0.36%17.89B | -0.36%17.89B | -3.57%17.64B | -5.47%17.25B | -6.91%17.06B | -8.89%17.95B | -8.89%17.95B | -6.01%18.29B |
Total equity | 1.33%17.48B | 0.68%17.18B | -0.36%17.89B | -0.36%17.89B | -3.57%17.64B | -5.47%17.25B | -6.91%17.06B | -8.89%17.95B | -8.89%17.95B | -6.01%18.29B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |